Catalyst Wire Dossier Catalyst Wire Dossier

Yinqiaosan-Maxingganshitang

· Chinese University of Hong Kong
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Yinqiaosan-Maxingganshitang, covering 2023-07-07 to 2023-07-07. Get the full timeline:

Most recent: Clinical Trial Update: RCT for Yinqiaosan-Maxingganshitang in the Treatment of COVID-19 [Phase 2]

See pricing